Author:
Al-Tweigeri Taher,Dent Susan,Al Sayed Adher,Mohty Dania,Suleman Kausar,Ajarim Dahish,Raef Hussein,Echahidi Najmeddine
Subject
Oncology,Hematology,General Medicine
Reference14 articles.
1. Association of QT-prolonging medications with risk of autopsy-defined causes of sudden death;Simpson;JAMA Intern Med,2020
2. Molecularly targeted oncology therapeutics and prolongation of the QT interval;Strevel;J Clin Oncol,2007
3. QT assessment in early drug development: the long and the short of It;Lester;Int J Mol Sci,2019
4. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Steering Committee. ICH Harmonized Tripartite Guideline: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs, E14.Geneva, and Switzerland: International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; Available online:http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Q_As_R3.2005 Step4.pdf
5. AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献